BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1634 related articles for article (PubMed ID: 28335021)

  • 21. White matter hyperintensities: relationship to amyloid and tau burden.
    Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
    Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter perivascular spaces are related to cortical superficial siderosis in cerebral amyloid angiopathy.
    Charidimou A; Jäger RH; Peeters A; Vandermeeren Y; Laloux P; Baron JC; Werring DJ
    Stroke; 2014 Oct; 45(10):2930-5. PubMed ID: 25116879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.
    Jack CR; Lowe VJ; Senjem ML; Weigand SD; Kemp BJ; Shiung MM; Knopman DS; Boeve BF; Klunk WE; Mathis CA; Petersen RC
    Brain; 2008 Mar; 131(Pt 3):665-80. PubMed ID: 18263627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy.
    Charidimou A; Ni J; Martinez-Ramirez S; Vashkevich A; Ayres A; Rosand J; Gurol EM; Greenberg SM; Viswanathan A
    Cerebrovasc Dis; 2016; 41(3-4):156-62. PubMed ID: 26751369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. White matter hyperintensities predict amyloid increase in Alzheimer's disease.
    Grimmer T; Faust M; Auer F; Alexopoulos P; Förstl H; Henriksen G; Perneczky R; Sorg C; Yousefi BH; Drzezga A; Kurz A
    Neurobiol Aging; 2012 Dec; 33(12):2766-73. PubMed ID: 22410648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
    Wakabayashi Y; Ishii K; Hosokawa C; Hyodo T; Kaida H; Yamada M; Yagyu Y; Tsurusaki M; Kozuka T; Sugimura K; Murakami T
    Kobe J Med Sci; 2017 Mar; 62(5):E136-E141. PubMed ID: 28289271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
    Jung NY; Han JC; Ong YT; Cheung CY; Chen CP; Wong TY; Kim HJ; Kim YJ; Lee J; Lee JS; Jang YK; Kee C; Lee KH; Kim EJ; Seo SW; Na DL
    J Neurol Sci; 2019 Jan; 396():94-101. PubMed ID: 30447606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
    Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
    J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, Neuropsychological, and Neuroimaging Characteristics of Amyloid- positive vs. Amyloid-negative Patients with Clinically Diagnosed Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Wang Y; Lou F; Li Y; Liu F; Wang Y; Cai L; Gordon ML; Zhang Y; Zhang N
    Curr Alzheimer Res; 2021; 18(6):523-532. PubMed ID: 34598664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.
    Johnson KA; Gregas M; Becker JA; Kinnecom C; Salat DH; Moran EK; Smith EE; Rosand J; Rentz DM; Klunk WE; Mathis CA; Price JC; Dekosky ST; Fischman AJ; Greenberg SM
    Ann Neurol; 2007 Sep; 62(3):229-34. PubMed ID: 17683091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
    J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex.
    Perosa V; Oltmer J; Munting LP; Freeze WM; Auger CA; Scherlek AA; van der Kouwe AJ; Iglesias JE; Atzeni A; Bacskai BJ; Viswanathan A; Frosch MP; Greenberg SM; van Veluw SJ
    Acta Neuropathol; 2022 Mar; 143(3):331-348. PubMed ID: 34928427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid deposition in early onset versus late onset Alzheimer's disease.
    Cho H; Seo SW; Kim JH; Suh MK; Lee JH; Choe YS; Lee KH; Kim JS; Kim GH; Noh Y; Ye BS; Kim HJ; Yoon CW; Chin J; Na DL
    J Alzheimers Dis; 2013; 35(4):813-21. PubMed ID: 23507771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.